We are live on ! Find out more
CTIC

CTI BioPharma Corp. (DE) Common Stock
CTIC

Delisted

CTIC was delisted on the 23rd of June, 2023.

Back to rankings

67 hedge funds and large institutions have $52M invested in CTI BioPharma Corp. (DE) Common Stock in 2013 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 16 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more capital invested

Capital invested by funds: $25.9M → $52M (+$26M)

56% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 16

38% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 13

5% more funds holding

Funds holding: 64 → 67 (+3)

98% less call options, than puts

Call options by funds: $6K | Put options by funds: $282K

Holders
67
Holders Change
+3
Holders Change %
+4.69%
% of All Funds
2.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
25
Reduced
16
Closed
13
Calls
$6K
Puts
$282K
Net Calls
-$276K
Net Calls Change
-$91K

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$8.1M
2
Northern Trust
Northern Trust
Illinois
+$1.15M
3
State Street
State Street
Massachusetts
+$1.04M
4
BFA
BlackRock Fund Advisors
California
+$427K
5
CS
Credit Suisse
Switzerland
+$375K

Top Sellers

Rank Fund Capital Flow
1
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$782K
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$612K
3
Morgan Stanley
Morgan Stanley
New York
-$300K
4
Bank of America
Bank of America
North Carolina
-$166K
5
Jane Street
Jane Street
New York
-$150K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$11.3M +$8.1M +699,467 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$10.3M – – –
BIT
3
BlackRock Institutional Trust
California
$5.71M +$139K +11,993 +4%
BFA
4
BlackRock Fund Advisors
California
$5.15M +$427K +36,810 +13%
Vanguard Group
5
Vanguard Group
Pennsylvania
$3.72M +$126K +10,899 +5%
Northern Trust
6
Northern Trust
Illinois
$2.34M +$1.15M +99,113 +218%
State Street
7
State Street
Massachusetts
$1.97M +$1.04M +90,060 +296%
BA
8
BlackRock Advisors
Delaware
$1.25M +$9.51K +821 +1%
D.E. Shaw & Co
9
D.E. Shaw & Co
New York
$843K -$612K -52,805 -51%
Jane Street
10
Jane Street
New York
$792K -$150K -12,979 -21%
TCIM
11
TIAA CREF Investment Management
New York
$787K -$118K -10,143 -17%
CS
12
Credit Suisse
Switzerland
$740K +$375K +32,328 +242%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$624K +$123K +10,595 +39%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$594K -$1.43K -123 -0.3%
WT
15
Washington Trust
Rhode Island
$562K +$101K +8,696 +33%
BIM
16
BlackRock Investment Management
Delaware
$517K +$33.5K +2,894 +10%
Jacobs Levy Equity Management
17
Jacobs Levy Equity Management
New Jersey
$436K -$782K -67,469 -71%
Morgan Stanley
18
Morgan Stanley
New York
$366K -$300K -25,901 -53%
California State Teachers Retirement System (CalSTRS)
19
California State Teachers Retirement System (CalSTRS)
California
$331K +$6.14K +530 +3%
ZIM
20
Zacks Investment Management
Illinois
$327K -$17.1K -1,479 -7%
TA
21
Teachers Advisors
New York
$272K +$26.9K +2,318 +16%
Charles Schwab
22
Charles Schwab
California
$267K – – –
Deutsche Bank
23
Deutsche Bank
Germany
$243K +$93.2K +8,045 +115%
UCFA
24
United Capital Financial Advisors
Texas
$214K +$153K +13,224 New
RhumbLine Advisers
25
RhumbLine Advisers
Massachusetts
$165K +$1.16K +100 +1%
1
2 3 4

CTIC Hedge Fund Activity: Q3 2013 in Review

67 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in CTI BioPharma Corp. (DE) Common Stock (CTIC) for Q3 2013, worth a combined $52M — up 100% from $25.9M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new CTIC positions and 13 closed out — a net gain of 5 holders — while 25 added to existing stakes and 16 trimmed.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $8.1M. The largest seller was Jacobs Levy Equity Management, cutting an estimated $782K.

  • 67 institutional investors held CTI BioPharma Corp. (DE) Common Stock (CTIC) as of Q3 2013, up from 64 in Q2 2013.
  • Funds reported $52M of CTI BioPharma Corp. (DE) Common Stock stock for Q3 2013, up 100% quarter-over-quarter.
  • 18 funds opened new CTI BioPharma Corp. (DE) Common Stock positions in Q3 2013 and 13 closed out, a net change of +5 holders.
  • The largest CTI BioPharma Corp. (DE) Common Stock buyer in Q3 2013 was Perceptive Advisors, an estimated $8.1M added.
  • The largest CTI BioPharma Corp. (DE) Common Stock seller in Q3 2013 was Jacobs Levy Equity Management, an estimated $782K sold.

Based on aggregated 13F filings for Q3 2013.